STOCK TITAN

Amrize Announces Date for Second Quarter 2025 Financial Results

Amrize (NYSE: AMRZ) has scheduled its second quarter 2025 financial results announcement for August 6, 2025, after U.S. market hours.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CHICAGO--(BUSINESS WIRE)-- Amrize (NYSE: AMRZ) will publish its second quarter 2025 financial results after the U.S. market closes on Wednesday, August 6, 2025, followed by a webcast to discuss the company’s financial results at 9:00 am Eastern Time on Thursday, August 7, 2025.

Registration for the Q2 2025 live webcast can be completed at https://amrize-quarterly-results-q2-2025.open-exchange.net/

Amrize’s financial results, presentation materials and webcast will be accessible in the events section of www.amrize.com/investors. A replay and transcript will be available at the same location following the webcast.

About Amrize

Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network, we deliver for our customers in every U.S. state and Canadian province. Our 19,000 teammates uniquely serve every construction market from infrastructure, commercial and residential to new build, repair and refurbishment. Amrize achieved $11.7 billion in revenue in 2024 and is listed on the New York Stock Exchange and the SIX Swiss Exchange. We are ready to build your ambition.

Media Relations: media@amrize.com
+1 773-676-4981

Investor Relations: investors@amrize.com
+1 773-355-4404

Source: Amrize

Keep reading